Status:
UNKNOWN
Effects of MET vs Mulligan MWM on Pain, Disability & Balance in Athletes With Ankle Sprain
Lead Sponsor:
Riphah International University
Conditions:
Chronic Ankle Sprain
Eligibility:
MALE
20-35 years
Phase:
NA
Brief Summary
Ankle Sprains are the most common injury in Athletes and have a high rate of recurrence, pain, dynamic balance and disability is the leading cause of season break in athletes with chronic ankle sprain...
Detailed Description
Ankle Sprains are the most common injury in Athletes and have a high rate of recurrence, pain, dynamic balance and disability is the leading cause of season break in athletes with chronic ankle sprain...
Eligibility Criteria
Inclusion
- Diagnosed cases of chronic ankle sprain (grade I or II) (3-4 months)
- Players have spent at least one year in sports
Exclusion
- • Players undergone surgery or had an accident.
- Any malignant or chronic disease
- Players with the history of fracture in the same ankle
Key Trial Info
Start Date :
October 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05393310
Start Date
October 25 2021
End Date
December 1 2022
Last Update
September 7 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pakistan sports board
Lahore, Punjab Province, Pakistan, 5433
2
PSB
Lahore, Punjab Province, Pakistan, 5433